Search Results

NINDS Halts SAMMPRIS Trial of Intracranial Angioplasty With Stenting

April 11, 2011—The National Institute of Neurological Disorders and Stroke (NINDS) has issued a clinical alert that it has stopped enrollment in the SAMMPRIS (Stenting vs Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis) trial.

Enrollment Completed in Pivotal Trial of Essential Medical's Manta Large-Bore Vascular Closure Device

October 2, 2017—Essential Medical, Inc. announced the completion of enrollment in the United States pivotal trial of its Manta large-bore vascular closure device.

FDA Approves MicroVention's Web Intrasaccular Aneurysm Embolization System

January 7, 2019—MicroVention, Inc., a United States–based subsidiary of Terumo, announced FDA premarket approval for its Web aneurysm embolization system for the treatment of intracranial wide-neck bifurcation aneurysms.

CE Mark Granted for Sequent Medical's Web SL Family of Neurovascular Aneurysm Embolization Devices

May 20, 2013—Sequent Medical, Inc. (Aliso Viejo, CA) announced that it has received CE Mark approval for the SL (single-layer) family of Web aneurysm embolization devices and has commenced a controlled release of these new models in select neurovascular centers in Europe.

Terumo Completes Acquisition of Sequent Medical

July 14, 2016—MicroVention, Inc., a wholly owned subsidiary of Tokyo-based Terumo Corporation, announced that Terumo Corporation has completed the acquisition of Sequent Medical, Inc., a privately held medical device firm based in Aliso Viejo, California, with European operations based in Bonn, Germany.

Terumo Acquires Sequent Medical

June 14, 2016—Terumo Corporation announced that it has entered into an agreement to purchase Sequent Medical, Inc. for $280 million to be paid at closing, with up to $100 million more to be paid based on the achievement of specific development or commercial milestones.

MicroVention Announces New Sizes of Web System and 5-Year WEB-IT Trial Data

July 31, 2023—MicroVention, Inc., a wholly owned subsidiary of Terumo Corporation, announced the addition of two sizes to its Web aneurysm embolization system.

Real-World Experience Reported for Sequent Medical's WEB Device to Treat Cerebral Aneurysms

April 20, 2016—Christin Clajus, MD, et al have published findings demonstrating real-world experience in the use of all iterations of the Woven EndoBridge—WEB—cerebral aneurysm embolization device (Sequent Medical, Inc.) in ruptured and unruptured aneurysms.

Enrollment Completed in WEB-IT Study for Sequent Medical's Aneurysm Embolization System

March 8, 2016—Sequent Medical, Inc. announced today that it has completed patient enrollment in its investigational device exemption pivotal trial to evaluate the safety and effectiveness of the Web aneurysm embolization system.

IDE Study Begins for Sequent Medical's Web Aneurysm Embolization System

August 28, 2014—Sequent Medical, Inc. announced that it has initiated patient enrollment in the WEB-IT (Web intrasaccular therapy) study.

Gore Launches Web Site for Ultimate SAAAVE Public Awareness Campaign

March 30, 2010—W.

Data Support Sequent Medical's Web Aneurysm Embolization System

November 14, 2013—Sequent Medical, Inc. (Aliso Viejo, CA) announced the presentation of long-term results from a retrospective study of the company’s Web aneurysm embolization system at the World Federation of Interventional Neuroradiology Congress in Buenos Aires, Argentina.

Sequent Medical's Via Microcatheter Receives CE Mark Approval for Cerebral Aneurysm Treatment

December 11, 2012—Sequent Medical, Inc. (Aliso Viejo, CA) announced it has received CE Mark approval for the Via microcatheter.

European CLARYS Study Begins for Sequent Medical's Web Aneurysm Embolization System in Ruptured Intracranial Aneurysms

February 12, 2016—Sequent Medical, Inc. announced that it has commenced patient enrollment in the CLARYS study, which is evaluating the safety and effectiveness of the company’s Web aneurysm embolization system for the treatment of ruptured intracranial aneurysms.